Ran-Ropinirole · DIN 02314088 · 5 mg · tablet
General benefitMarketed · checked November 17, 2026
StatusGeneral benefit
Write on scriptno code needed
Patient paysODB senior: $100/program-year deductible
• Then up to $6.11 per prescription
Or, if enrolled in the Seniors Co-Payment Program (income-tested; individual net income below $25,480 for Aug 2026–Jul 2027): no deductible, up to $2 per prescription
Private plan not entered. Private-plan coverage, and how it coordinates with public programs, is not determined here; the Ontario public-program lines on this page remain conditional on the entered details and the program rules.
1 brand, same coverage
Ran-Ropinirole · DIN 02314088
Manufacturer: Ranbaxy Pharmaceuticals Canada Inc.; listing date 2009-09-30
Health Canada: Marketed since 2025-06-26 · brand SPC-ROPINIROLE · ATC N04BC04 ROPINIROLE · form Tablet · route Oral · ingredients ROPINIROLE (ROPINIROLE HYDROCHLORIDE) 5 MG · company Sun pharma canada inc · schedule Prescription
Ran-Ropinirole: Formulary list price $1.75 per unit (the source does not state the unit; exact figure $1.7450). What the ministry pays, not the patient.
Formulary data: Ontario extract of September 22, 2026 · Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · Health Canada DPD page · Verify on the e-Formulary ↗ (DIN 02314088)
Source record
DIN 02314088: Ran-Ropinirole
Raw flags: sec3=Y
Item: 920000292; group id 956; item number 2272; lccId None; manufacturer id RAN
Source form: Tab; strength: 5mg
Recorded listing: General benefit
Source prices (unrounded): $1.7450; ministry $1.7450
Source: ODB odb-formulary-ed43-extract-2026-09-22.xml extract_date=September 22, 2026 DIN=02314088
Health Canada DPD extract of October 5, 2026 (Open Government Licence – Canada) · https://health-products.canada.ca/dpd-bdpp/info?lang=eng&code=79959
Interchangeable products
ReQuip · DIN 02232569 · not recorded
Teva-Ropinirole · DIN 02316870 · $1.7450
Shortage status: not checked (no credentials)